Key result
Patients with NSTEMI had a higher rate of 3-year all-cause mortality after discharge compared to patients with STEMI.
Why the study?
The study was designed to compare post-discharge mortality rates and identify specific mortality risk factors between patients with NSTEMI and STEMI.
Does NSTEMI compared to STEMI have different long-term mortality rates after discharge in patients with acute myocardial infarction?
Observational (n=12,271)
Yes
Does NSTEMI compared to STEMI have different long-term mortality rates after discharge in patients with acute myocardial infarction?
Patients with NSTEMI have a significantly higher long-term all-cause and cardiac mortality rate after discharge compared to those with STEMI, with low LVEF and lack of PCI being major risk factors in the NSTEMI population.
Answers are grounded in this paper and cite their sources.
NSTEMI survivors warrant closer post-discharge monitoring than STEMI; observational data leave open whether targeted strategies improve outcomes.
PURPOSE: This study aimed to compare mortality rates after discharge between the patients with non-ST-elevation myocardial infarction (NSTEMI) and those with ST-elevation myocardial infarction (STEMI), and identify each mortality risk factors in these two types of myocardial infarction. MATERIALS AND METHODS: Between 2011 and 2015, 13105 consecutive patients were enrolled in the Korea Acute Myocardial Infarction-National Institute of Health registry (KAMIR-NIH); 12271 patients with acute myocardial infarction met the inclusion criteria and were further stratified into the STEMI (n=5828) and NSTEMI (n=6443) groups. The occurrence of mortality and cardiac mortality at 3 years were compared between groups, and the factors associated with mortality for NSTEMI and STEMI were evaluated. RESULTS: <0.001, respectively). In the NSTEMI group, low left ventricular ejection fraction (LVEF; <40%), no percutaneous coronary intervention (PCI), old age (≥65 years), and low hemoglobin level (<12 g/dL) were identified as risk factors for 3-year mortality. In the STEMI group, old age, low glomerular filtration rate (<60 mL/min/1.73 m²), low LVEF, high heart rate (>100 beats/min), no PCI, and low hemoglobin level were identified as the risk factors for 3-year mortality. CONCLUSION: The NSTEMI group had higher mortality compared to the STEMI group during the 3-year clinical follow-up after discharge. Low LVEF and no PCI were the main risk factors for mortality in the NSTEMI group. In contrast, old age and renal dysfunction were the risk factors for long-term mortality in the STEMI group.
No takes yet. Share an insight, caveat, or question.
Han et al. (2021) conducted an observational in Acute myocardial infarction (n=12,271). Non-ST-elevation myocardial infarction (NSTEMI) vs. ST-elevation myocardial infarction (STEMI) was evaluated on All-cause mortality at 3 years after discharge (HR 0.615, 95% CI 0.528-0.716, p=<0.001). Patients with NSTEMI had a higher rate of 3-year all-cause mortality after discharge compared to patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: